Skip to main content
OpenTrials

Clinical trial condition

Metastatic Renal Cell Carcinoma

Explore clinical trials studying Metastatic Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

125 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Renal Cell Carcinoma trial results

Recruiting

Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients

NCT05817903

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • ASST degli Spedali Civili di Brescia Brescia, Italy
  • Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia - IRCCS Candiolo, Italy
  • Azienda Ospedaliera per l'emergenza Cannizzaro Catania, Italy
  • ASST di Cremona Cremona, Italy
View all 23 locations
View Trial Details
Completed

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

NCT02231749

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • Local Institution - 0006 Duarte, California, United States
  • Local Institution - 0057 La Jolla, California, United States
  • Local Institution - 0044 Los Angeles, California, United States
  • Local Institution - 0035 Los Angeles, California, United States
View all 189 locations
View Trial Details

Related conditions